DrugPatentWatch Database Preview
Details for Patent: 8,071,737
Title: | Nucleic acid ligand complexes |
Abstract: | This invention discloses a method for preparing a therapeutic or diagnostic complex comprised of a nucleic acid ligand and a lipophilic compound or non-immunogenic, high molecular weight compound by identifying a nucleic acid ligand by SELEX methodology and associating the nucleic acid ligand with a lipophilic compound or a non-immunogenic, high molecular weight compound. The invention further discloses complexes comprising one or more nucleic acid ligands in association with a lipophilic compound or non-immunogenic, high molecular weight compound. |
Inventor(s): | Gold; Larry (Boulder, CO), Schmidt; Paul (Niwot, CO), Janjic; Nebojsa (Boulder, CO) |
Assignee: | Glead Sciences, Inc. (Forster City, CA) |
Filing Date: | Nov 23, 2009 |
Application Number: | 12/624,314 |
Claims: | 1. A method for imaging a site expressing a Target in a patient, the method comprising: covalently linking a Nucleic Acid Ligand with magnetite, wherein said Nucleic Acid Ligand has a specific binding affinity for said Target; administering said Nucleic Acid Ligand associated with magnetite to a patient; and performing nuclear magnetic resonance (NMR) imaging. |